Literature DB >> 29021297

Parkinson's Disease Is Not Simply a Prion Disorder.

D James Surmeier1, José A Obeso2,3, Glenda M Halliday4,5.   

Abstract

The notion that prion-like spreading of misfolded α-synuclein (α-SYN) causes Parkinson's disease (PD) has received a great deal of attention. Although attractive in its simplicity, the hypothesis is difficult to reconcile with postmortem analysis of human brains and connectome-mapping studies. An alternative hypothesis is that PD pathology is governed by regional or cell-autonomous factors. Although these factors provide an explanation for the pattern of neuronal loss in PD, they do not readily explain the apparently staged distribution of Lewy pathology in many PD brains, the feature of the disease that initially motivated the spreading hypothesis by Braak and colleagues. While each hypothesis alone has its shortcomings, a synthesis of the two can explain much of what we know about the etiopathology of PD.Dual Perspectives Companion Paper: Prying into the Prion Hypothesis for Parkinson's Disease, by Patrik Brundin and Ronald Melki.
Copyright © 2017 the authors 0270-6474/17/379799-09$15.00/0.

Entities:  

Keywords:  aging; alpha-synuclein; calcium; mitochondria; neurodegeneration; neuron; selective vulnerability; synapse

Mesh:

Substances:

Year:  2017        PMID: 29021297      PMCID: PMC5637112          DOI: 10.1523/JNEUROSCI.1787-16.2017

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  148 in total

Review 1.  Autophagy gone awry in neurodegenerative diseases.

Authors:  Esther Wong; Ana Maria Cuervo
Journal:  Nat Neurosci       Date:  2010-07       Impact factor: 24.884

2.  Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease.

Authors:  G M Halliday; P C Blumbergs; R G Cotton; W W Blessing; L B Geffen
Journal:  Brain Res       Date:  1990-02-26       Impact factor: 3.252

Review 3.  Genes associated with Parkinson's disease: regulation of autophagy and beyond.

Authors:  Alexandra Beilina; Mark R Cookson
Journal:  J Neurochem       Date:  2015-09-03       Impact factor: 5.372

4.  Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

Authors:  John E Duda; Benoit I Giasson; Meghann E Mabon; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2002-08       Impact factor: 10.422

5.  Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease.

Authors:  G M Halliday; D A McRitchie; H Cartwright; R Pamphlett; M A Hely; J G Morris
Journal:  J Clin Neurosci       Date:  1996-01       Impact factor: 1.961

6.  Use of calcium channel blockers and Parkinson's disease.

Authors:  Björn Pasternak; Henrik Svanström; Nete M Nielsen; Lars Fugger; Mads Melbye; Anders Hviid
Journal:  Am J Epidemiol       Date:  2012-03-01       Impact factor: 4.897

Review 7.  α-Synuclein and dopamine at the crossroads of Parkinson's disease.

Authors:  Lara Lourenço Venda; Stephanie J Cragg; Vladimir L Buchman; Richard Wade-Martins
Journal:  Trends Neurosci       Date:  2010-10-18       Impact factor: 13.837

8.  Caudo-rostral brain spreading of α-synuclein through vagal connections.

Authors:  Ayse Ulusoy; Raffaella Rusconi; Blanca I Pérez-Revuelta; Ruth E Musgrove; Michael Helwig; Bettina Winzen-Reichert; Donato A Di Monte
Journal:  EMBO Mol Med       Date:  2013-05-23       Impact factor: 12.137

Review 9.  Neuronal calcium signaling: function and dysfunction.

Authors:  Marisa Brini; Tito Calì; Denis Ottolini; Ernesto Carafoli
Journal:  Cell Mol Life Sci       Date:  2014-01-19       Impact factor: 9.261

Review 10.  Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders.

Authors:  Martin Ingelsson
Journal:  Front Neurosci       Date:  2016-09-05       Impact factor: 4.677

View more
  66 in total

1.  Alpha-synuclein: prion or prion-like?

Authors:  Rehana K Leak; Matthew P Frosch; Thomas G Beach; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2019-08-12       Impact factor: 17.088

2.  Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Elaine Bandeira Cavalcanti Duarte; Laura Maria Ramos Miranda; Andore Guescel C Asano; Nadja Maria Jorge Asano; Maria de Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Neuromolecular Med       Date:  2019-05-22       Impact factor: 3.843

Review 3.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

Review 4.  Parkinson's disease from the gut.

Authors:  Rodger A Liddle
Journal:  Brain Res       Date:  2018-01-31       Impact factor: 3.252

5.  Motor Neurons Pathology After Chronic Exposure to MPTP in Mice.

Authors:  Giorgio Vivacqua; Francesca Biagioni; Carla L Busceti; Michela Ferrucci; Michele Madonna; Larisa Ryskalin; Shun Yu; Loredana D'Este; Francesco Fornai
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

Review 6.  The pedunclopontine nucleus and Parkinson's disease.

Authors:  Cecilia Tubert; Daniel Galtieri; D James Surmeier
Journal:  Neurobiol Dis       Date:  2018-08-29       Impact factor: 5.996

Review 7.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

Review 8.  Selective vulnerability in neurodegenerative diseases.

Authors:  Hongjun Fu; John Hardy; Karen E Duff
Journal:  Nat Neurosci       Date:  2018-09-24       Impact factor: 24.884

9.  Regional subcortical shape analysis in premanifest Huntington's disease.

Authors:  Xiaoying Tang; Christopher A Ross; Hans Johnson; Jane S Paulsen; Laurent Younes; Roger L Albin; J Tilak Ratnanather; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2018-10-30       Impact factor: 5.038

Review 10.  Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease.

Authors:  David Weinshenker
Journal:  Trends Neurosci       Date:  2018-02-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.